Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Background As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. Methods We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between incidence, prevalence, remission, and cause of death rates for each condition. For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated to cause level. We updated the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. GBD 2016 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, low back pain, migraine, age-related and other hearing loss, iron-deficiency anaemia, and major depressive disorder were the five leading causes of YLDs in 2016, contributing 57·6 million (95% uncertainty interval [UI] 40·8-75·9 million [7·2%, 6·0-8·3]), 45·1 million (29·0-62·8 million [5·6%, 4·0-7·2]), 36·3 million (25·3-50·9 million [4·5%, 3·8-5·3]), 34·7 million (23·0-49·6 million [4·3%, 3·5-5·2]), and 34·1 million (23·5-46·0 million [4·2%, 3·2-5·3]) of total YLDs, respectively. Age-standardised rates of YLDs for all causes combined decreased between 1990 and 2016 by 2·7% (95% UI 2·3-3·1). Despite mostly stagnant age-standardised rates, the absolute number of YLDs from non-communicable diseases has been growing rapidly across all SDI quintiles, partly because of population growth, but also the ageing of populations. The largest absolute increases in total numbers of YLDs globally were between the ages of 40 and 69 years. Age-standardised YLD rates for all conditions combined were 10·4% (95% UI 9·0-11·8) higher in women than in men. Iron-deficiency anaemia, migraine, Alzheimer's disease and other dementias, major depressive disorder, anxiety, and all musculoskeletal disorders apart from gout were the main conditions contributing to higher YLD rates in women. Men had higher age-standardised rates of substance use disorders, diabetes, cardiovascular diseases, cancers, and all injuries apart from sexual violence. Globally, we noted much less geographical variation in disability than has been documented for premature mortality. In 2016, there was a less than two times difference in age-standardised YLD rates for all causes between the location with the lowest rate (China, 9201 YLDs per 100 000, 95% UI 6862-11943) and highest rate (Yemen, 14 774 YLDs per 100 000, 11 018-19 228). Interpretation The decrease in death rates since 1990 for most causes has not been matched by a similar decline in age-standardised YLD rates. For many large causes, YLD rates have either been stagnant or have increased for some causes, such as diabetes. As populations are ageing, and the prevalence of disabling disease generally increases steeply with age, health systems will face increasing demand for services that are generally costlier than the interventions that have led to declines in mortality in childhood or for the major causes of mortality in adults. Up-todate information about the trends of disease and how this varies between countries is essential to plan for an adequate health-system response.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
Vos T.;Abajobir A. A.;Abbafati C.;Abbas K. M.;Abate K. H.;Abd-Allah F.;Abdulle A. M.;Abebo T. A.;Abera S. F.;Aboyans V.;Abu-Raddad L. J.;Ackerman I. N.;Adamu A. A.;Adetokunboh O.;Afarideh M.;Afshin A.;Agarwal S. K.;Aggarwal R.;Agrawal A.;Agrawal S.;Ahmad Kiadaliri A.;Ahmadieh H.;Ahmed M. B.;Aichour A. N.;Aichour I.;Aichour M. T. E.;Aiyar S.;Akinyemi R. O.;Akseer N.;Al Lami F. H.;Alahdab F.;Al-Aly Z.;Alam K.;Alam N.;Alam T.;Alasfoor D.;Alene K. A.;Ali R.;Alizadeh-Navaei R.;Alkerwi A.;Alla F.;Allebeck P.;Allen C.;Al-Maskari F.;Al-Raddadi R.;Alsharif U.;Alsowaidi S.;Altirkawi K. A.;Amare A. T.;Amini E.;Ammar W.;Amoako Y. A.;Andersen H. H.;Antonio C. A. T.;Anwari P.;Arnlov J.;Artaman A.;Aryal K. K.;Asayesh H.;Asgedom S. W.;Assadi R.;Atey T. M.;Atnafu N. T.;Atre S. R.;Avila-Burgos L.;Avokpaho E. F. G. A.;Awasthi A.;Ayala Quintanilla B. P.;Ba Saleem H. O.;Bacha U.;Badawi A.;Balakrishnan K.;Banerjee A.;Bannick M. S.;Barac A.;Barber R. M.;Barker-Collo S. L.;Barnighausen T.;Barquera S.;Barregard L.;Barrero L. H.;Basu S.;Battista B.;Battle K. E.;Baune B. T.;Bazargan-Hejazi S.;Beardsley J.;Bedi N.;Beghi E.;Bejot Y.;Bekele B. B.;Bell M. L.;Bennett D. A.;Bensenor I. M.;Benson J.;Berhane A.;Berhe D. F.;Bernabe E.;Betsu B. D.;Beuran M.;Beyene A. S.;Bhala N.;Bhansali A.;Bhatt S.;Bhutta Z. A.;Biadgilign S.;Bienhoff K.;Bikbov B.;Birungi C.;Biryukov S.;Bisanzio D.;Bizuayehu H. M.;Boneya D. J.;Boufous S.;Bourne R. R. A.;Brazinova A.;Brugha T. S.;Buchbinder R.;Bulto L. N. B.;Bumgarner B. R.;Butt Z. A.;Cahuana-Hurtado L.;Cameron E.;Car M.;Carabin H.;Carapetis J. R.;Cardenas R.;Carpenter D. O.;Carrero J. J.;Carter A.;Carvalho F.;Casey D. C.;Caso V.;Castaneda-Orjuela C. A.;Castle C. D.;Catala-Lopez F.;Chang H. -Y.;Chang J. -C.;Charlson F. J.;Chen H.;Chibalabala M.;Chibueze C. E.;Chisumpa V. H.;Chitheer A. A.;Christopher D. J.;Ciobanu L. G.;Cirillo M.;Colombara D.;Cooper C.;Cortesi P. A.;Criqui M. H.;Crump J. A.;Dadi A. F.;Dalal K.;Dandona L.;Dandona R.;Das Neves J.;Davitoiu D. V.;De Courten B.;De Leo D.;Degenhardt L.;Deiparine S.;Dellavalle R. P.;Deribe K.;Des Jarlais D. C.;Dey S.;Dharmaratne S. D.;Dhillon P. K.;Dicker D.;Ding E. L.;Djalalinia S.;Do H. P.;Dorsey E. R.;Dos Santos K. P. B.;Douwes-Schultz D.;Doyle K. E.;Driscoll T. R.;Dubey M.;Duncan B. B.;El-Khatib Z. Z.;Ellerstrand J.;Enayati A.;Endries A. Y.;Ermakov S. P.;Erskine H. E.;Eshrati B.;Eskandarieh S.;Esteghamati A.;Estep K.;Fanuel F. B. B.;Farinha C. S. E. S.;Faro A.;Farzadfar F.;Fazeli M. S.;Feigin V. L.;Fereshtehnejad S. -M.;Fernandes J. C.;Ferrari A. J.;Feyissa T. R.;Filip I.;Fischer F.;Fitzmaurice C.;Flaxman A. D.;Flor L. S.;Foigt N.;Foreman K. J.;Franklin R. C.;Fullman N.;Furst T.;Furtado J. M.;Futran N. D.;Gakidou E.;Ganji M.;Garcia-Basteiro A. L.;Gebre T.;Gebrehiwot T. T.;Geleto A.;Gemechu B. L.;Gesesew H. A.;Gething P. W.;Ghajar A.;Gibney K. B.;Gill P. S.;Gillum R. F.;Ginawi I. A. M.;Giref A. Z.;Gishu M. D.;Giussani G.;Godwin W. W.;Gold A. L.;Goldberg E. M.;Gona P. N.;Goodridge A.;Gopalani S. V.;Goto A.;Goulart A. C.;Griswold M.;Gugnani H. C.;Gupta R.;Gupta R.;Gupta T.;Gupta V.;Hafezi-Nejad N.;Hailu A. D.;Hailu G. B.;Hamadeh R. R.;Hamidi S.;Handal A. J.;Hankey G. J.;Hao Y.;Harb H. L.;Hareri H. A.;Haro J. M.;Harvey J.;Hassanvand M. S.;Havmoeller R.;Hawley C.;Hay R. J.;Hay S. I.;Henry N. J.;Heredia-Pi I. B.;Heydarpour P.;Hoek H. W.;Hoffman H. J.;Horita N.;Hosgood H. D.;Hostiuc S.;Hotez P. J.;Hoy D. G.;Htet A. S.;Hu G.;Huang H.;Huynh C.;Iburg K. M.;Igumbor E. U.;Ikeda C.;Irvine C. M. S.;Jacobsen K. H.;Jahanmehr N.;Jakovljevic M. B.;Jassal S. K.;Javanbakht M.;Jayaraman S. P.;Jeemon P.;Jensen P. N.;Jha V.;Jiang G.;John D.;Johnson C. O.;Johnson S. C.;Jonas J. B.;Jurisson M.;Kabir Z.;Kadel R.;Kahsay A.;Kamal R.;Kan H.;Karam N. E.;Karch A.;Karema C. K.;Kasaeian A.;Kassa G. M.;Kassaw N. A.;Kassebaum N. J.;Kastor A.;Katikireddi S. V.;Kaul A.;Kawakami N.;Keiyoro P. N.;Kengne A. P.;Keren A.;Khader Y. S.;Khalil I. A.;Khan E. A.;Khang Y. -H.;Khosravi A.;Khubchandani J.;Kieling C.;Kim D.;Kim P.;Kim Y. J.;Kimokoti R. W.;Kinfu Y.;Kisa A.;Kissimova-Skarbek K. A.;Kivimaki M.;Knudsen A. K.;Kokubo Y.;Kolte D.;Kopec J. A.;Kosen S.;Koul P. A.;Koyanagi A.;Kravchenko M.;Krishnaswami S.;Krohn K. J.;Kuate Defo B.;Kucuk Bicer B.;Kumar G. A.;Kumar P.;Kumar S.;Kyu H. H.;Lal D. K.;Lalloo R.;Lambert N.;Lan Q.;Larsson A.;Lavados P. M.;Leasher J. L.;Lee J. -T.;Lee P. H.;Leigh J.;Leshargie C. T.;Leung J.;Leung R.;Levi M.;Li Y.;Li Y.;Li Kappe D.;Liang X.;Liben M. L.;Lim S. S.;Linn S.;Liu A.;Liu P. Y.;Liu S.;Liu Y.;Lodha R.;Logroscino G.;London S. J.;Looker K. J.;Lopez A. D.;Lorkowski S.;Lotufo P. A.;Low N.;Lozano R.;Lucas T. C. D.;Macarayan E. R. K.;Magdy Abd El Razek H.;Magdy Abd El Razek M.;Mahdavi M.;Majdan M.;Majdzadeh R.;Majeed A.;Malekzadeh R.;Malhotra R.;Malta D. C.;Mamun A. A.;Manguerra H.;Manhertz T.;Mantilla A.;Mantovani L. G.;Mapoma C. C.;Marczak L. B.;Martinez-Raga J.;Martins-Melo F. R.;Martopullo I.;Marz W.;Mathur M. R.;Mazidi M.;McAlinden C.;McGaughey M.;McGrath J. J.;McKee M.;McNellan C.;Mehata S.;Mehndiratta M. M.;Mekonnen T. C.;Memiah P.;Memish Z. A.;Mendoza W.;Mengistie M. A.;Mengistu D. T.;Mensah G. A.;Meretoja A.;Meretoja T. J.;Mezgebe H. B.;Micha R.;Millear A.;Miller T. R.;Mills E. J.;Mirarefin M.;Mirrakhimov E. M.;Misganaw A.;Mishra S. R.;Mitchell P. B.;Mohammad K. A.;Mohammadi A.;Mohammed K. E.;Mohammed S.;Mohanty S. K.;Mokdad A. H.;Mollenkopf S. K.;Monasta L.;Hernandez J. M.;Montico M.;Moradi-Lakeh M.;Moraga P.;Mori R.;Morozoff C.;Morrison S. D.;Moses M.;Mountjoy-Venning C.;Mruts K. B.;Mueller U. O.;Muller K.;Murdoch M. E.;Murthy G. V. S.;Musa K. I.;Nachega J. B.;Nagel G.;Naghavi M.;Naheed A.;Naidoo K. S.;Naldi L.;Nangia V.;Natarajan G.;Negasa D. E.;Negoi I.;Negoi R. I.;Newton C. R.;Ngunjiri J. W.;Nguyen C. T.;Nguyen G.;Nguyen M.;Nguyen Q. L.;Nguyen T. H.;Nichols E.;Ningrum D. N. A.;Nolte S.;Nong V. M.;Norrving B.;Noubiap J. J. N.;O'Donnell M. J.;Ogbo F. A.;Oh I. -H.;Okoro A.;Oladimeji O.;Olagunju A. T.;Olagunju T. O.;Olsen H. E.;Olusanya B. O.;Olusanya J. O.;Ong K.;Opio J. N.;Oren E.;Ortiz A.;Osgood-Zimmerman A.;Osman M.;Owolabi M. O.;Pa M.;Pacella R. E.;Pana A.;Panda B. K.;Papachristou C.;Park E. -K.;Parry C. D.;Parsaeian M.;Patten S. B.;Patton G. C.;Paulson K.;Pearce N.;Pereira D. M.;Perico N.;Pesudovs K.;Peterson C. B.;Petzold M.;Phillips M. R.;Pigott D. M.;Pillay J. D.;Pinho C.;Plass D.;Pletcher M. A.;Popova S.;Poulton R. G.;Pourmalek F.;Prabhakaran D.;Prasad N.;Prasad N. M.;Purcell C.;Qorbani M.;Quansah R.;Rabiee R. H. S.;Radfar A.;Rafay A.;Rahimi K.;Rahimi-Movaghar A.;Rahimi-Movaghar V.;Rahman M.;Rahman M. H. U.;Rai R. K.;Rajsic S.;Ram U.;Ranabhat C. L.;Rankin Z.;Rao P. V.;Rao P. C.;Rawaf S.;Ray S. E.;Reiner R. C.;Reinig N.;Reitsma M. B.;Remuzzi G.;Renzaho A. M. N.;Resnikoff S.;Rezaei S.;Ribeiro A. L.;Ronfani L.;Roshandel G.;Roth G. A.;Roy A.;Rubagotti E.;Ruhago G. M.;Saadat S.;Sadat N.;Safdarian M.;Safi S.;Safiri S.;Sagar R.;Sahathevan R.;Salama J.;Salomon J. A.;Salvi S. S.;Samy A. M.;Sanabria J. R.;Santomauro D.;Santos I. S.;Santos J. V.;Santric Milicevic M. M.;Sartorius B.;Satpathy M.;Sawhney M.;Saxena S.;Schmidt M. I.;Schneider I. J. C.;Schottker B.;Schwebel D. C.;Schwendicke F.;Seedat S.;Sepanlou S. G.;Servan-Mori E. E.;Setegn T.;Shackelford K. A.;Shaheen A.;Shaikh M. A.;Shamsipour M.;Shariful Islam S. M.;Sharma J.;Sharma R.;She J.;Shi P.;Shields C.;Shigematsu M.;Shinohara Y.;Shiri R.;Shirkoohi R.;Shirude S.;Shishani K.;Shrime M. G.;Sibai A. M.;Sigfusdottir I. D.;Silva D. A. S.;Silva J. P.;Silveira D. G. A.;Singh J. A.;Singh N. P.;Sinha D. N.;Skiadaresi E.;Skirbekk V.;Slepak E. L.;Sligar A.;Smith D. L.;Smith M.;Sobaih B. H. A.;Sobngwi E.;Sorensen R. J. D.;Sousa T. C. M.;Sposato L. A.;Sreeramareddy C. T.;Srinivasan V.;Stanaway J. D.;Stathopoulou V.;Steel N.;Stein D. J.;Stein M. B.;Steiner C.;Steiner T. J.;Steinke S.;Stokes M. A.;Stovner L. J.;Strub B.;Subart M.;Sufiyan M. B.;Suliankatchi Abdulkader R.;Sunguya B. F.;Sur P. J.;Swaminathan S.;Sykes B. L.;Sylte D. O.;Tabares-Seisdedos R.;Taffere G. R.;Takala J. S.;Tandon N.;Tavakkoli M.;Taveira N.;Taylor H. R.;Tehrani-Banihashemi A.;Tekelab T.;Temam Shifa G.;Terkawi A. S.;Tesfaye D. J.;Tesssema B.;Thamsuwan O.;Thomas K. E.;Thrift A. G.;Tiruye T. Y.;Tobe-Gai R.;Tollanes M. C.;Tonelli M.;Topor-Madry R.;Tortajada M.;Touvier M.;Tran B. X.;Tripathi S.;Troeger C.;Truelsen T.;Tsoi D.;Tuem K. B.;Tuzcu E. M.;Tyrovolas S.;Ukwaja K. N.;Undurraga E. A.;Uneke C. J.;Updike R.;Uthman O. A.;Uzochukwu B. S. C.;Van Boven J. F. M.;Varughese S.;Vasankari T.;Venkatesh S.;Venketasubramanian N.;Vidavalur R.;Violante F. S.;Vladimirov S. K.;Vlassov V. V.;Vollset S. E.;Wadilo F.;Wakayo T.;Wang Y. -P.;Weaver M.;Weichenthal S.;Weiderpass E.;Weintraub R. G.;Werdecker A.;Westerman R.;Whiteford H. A.;Wijeratne T.;Wiysonge C. S.;Wolfe C. D. A.;Woodbrook R.;Woolf A. D.;Workicho A.;Wulf Hanson S.;Xavier D.;Xu G.;Yadgir S.;Yaghoubi M.;Yakob B.;Yan L. L.;Yano Y.;Ye P.;Yimam H. H.;Yip P.;Yonemoto N.;Yoon S. -J.;Yotebieng M.;Younis M. Z.;Zaidi Z.;Zaki M. E. S.;Zegeye E. A.;Zenebe Z. M.;Zhang X.;Zhou M.;Zipkin B.;Zodpey S.;Zuhlke L. J.;Murray C. J. L.
2017-01-01
Abstract
Background As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. Methods We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between incidence, prevalence, remission, and cause of death rates for each condition. For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated to cause level. We updated the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. GBD 2016 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, low back pain, migraine, age-related and other hearing loss, iron-deficiency anaemia, and major depressive disorder were the five leading causes of YLDs in 2016, contributing 57·6 million (95% uncertainty interval [UI] 40·8-75·9 million [7·2%, 6·0-8·3]), 45·1 million (29·0-62·8 million [5·6%, 4·0-7·2]), 36·3 million (25·3-50·9 million [4·5%, 3·8-5·3]), 34·7 million (23·0-49·6 million [4·3%, 3·5-5·2]), and 34·1 million (23·5-46·0 million [4·2%, 3·2-5·3]) of total YLDs, respectively. Age-standardised rates of YLDs for all causes combined decreased between 1990 and 2016 by 2·7% (95% UI 2·3-3·1). Despite mostly stagnant age-standardised rates, the absolute number of YLDs from non-communicable diseases has been growing rapidly across all SDI quintiles, partly because of population growth, but also the ageing of populations. The largest absolute increases in total numbers of YLDs globally were between the ages of 40 and 69 years. Age-standardised YLD rates for all conditions combined were 10·4% (95% UI 9·0-11·8) higher in women than in men. Iron-deficiency anaemia, migraine, Alzheimer's disease and other dementias, major depressive disorder, anxiety, and all musculoskeletal disorders apart from gout were the main conditions contributing to higher YLD rates in women. Men had higher age-standardised rates of substance use disorders, diabetes, cardiovascular diseases, cancers, and all injuries apart from sexual violence. Globally, we noted much less geographical variation in disability than has been documented for premature mortality. In 2016, there was a less than two times difference in age-standardised YLD rates for all causes between the location with the lowest rate (China, 9201 YLDs per 100 000, 95% UI 6862-11943) and highest rate (Yemen, 14 774 YLDs per 100 000, 11 018-19 228). Interpretation The decrease in death rates since 1990 for most causes has not been matched by a similar decline in age-standardised YLD rates. For many large causes, YLD rates have either been stagnant or have increased for some causes, such as diabetes. As populations are ageing, and the prevalence of disabling disease generally increases steeply with age, health systems will face increasing demand for services that are generally costlier than the interventions that have led to declines in mortality in childhood or for the major causes of mortality in adults. Up-todate information about the trends of disease and how this varies between countries is essential to plan for an adequate health-system response.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/363439
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
2405
5567
1466
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.
